hsa-miR-624-3p

ncRNA information

ncRNA name

hsa-miR-624-3p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

ARRDC3/YAP/HIF1Ī±

Cancer information

Cancer name

Esophageal Squamous Cell Carcinoma

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin/Paclitaxel

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MicroRNA-624-mediated ARRDC3/YAP/HIF1Ī± axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel

Tissue resource

esophageal squamous cell carcinoma cell lines KYSE150

esophageal squamous cell carcinoma cell lines KYSE450

esophageal squamous cell carcinoma cell lines KYSE410

esophageal squamous cell carcinoma cell lines KYSE510

Experiment

None


Institute

Roswell Park Memorial Institute

Country

Continent